Melexis N.V.
MLXSF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3,100 | $2,190 | $2,386 | $2,898 |
| - Cash | $39 | $34 | $35 | $33 |
| + Debt | $336 | $322 | $226 | $222 |
| Enterprise Value | $3,397 | $2,478 | $2,577 | $3,088 |
| Revenue | $253 | $212 | $198 | $197 |
| % Growth | 19.4% | 6.7% | 0.4% | – |
| Gross Profit | $98 | $83 | $76 | $78 |
| % Margin | 38.8% | 39% | 38.2% | 39.3% |
| EBITDA | $60 | $63 | $41 | $39 |
| % Margin | 23.9% | 30% | 20.8% | 20% |
| Net Income | $32 | $38 | $25 | $18 |
| % Margin | 12.8% | 17.9% | 12.4% | 9.3% |
| EPS Diluted | 0.81 | 0.94 | 0.61 | 0.45 |
| % Growth | -13.8% | 54.1% | 35.6% | – |
| Operating Cash Flow | $52 | $18 | $17 | $47 |
| Capital Expenditures | -$10 | -$8 | -$6 | -$12 |
| Free Cash Flow | $43 | $10 | $11 | $35 |